These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9499639)

  • 1. [Cholestatic liver diseases--diagnosis and therapy. 2: Diagnosis and clinical aspects of primary biliary cirrhosis (PBC)].
    Leuschner U
    Fortschr Med; 1997 Dec; 115(35-36):33-4. PubMed ID: 9499639
    [No Abstract]   [Full Text] [Related]  

  • 2. The detection of bile ducts in liver biopsies by cytokeratin 7.
    Rubio CA
    In Vivo; 1998; 12(2):183-6. PubMed ID: 9627800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunostaining of plasma cells in primary biliary cirrhosis.
    Daniels JA; Torbenson M; Anders RA; Boitnott JK
    Am J Clin Pathol; 2009 Feb; 131(2):243-9. PubMed ID: 19141384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratin 19 demonstration of canal of Hering loss in primary biliary cirrhosis: "minimal change PBC"?
    Khan FM; Komarla AR; Mendoza PG; Bodenheimer HC; Theise ND
    Hepatology; 2013 Feb; 57(2):700-7. PubMed ID: 22911653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presentation and diagnosis of 100 patients with primary biliary cirrhosis.
    Sherlock S; Scheuer PJ
    N Engl J Med; 1973 Sep; 289(13):674-8. PubMed ID: 4580473
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation between disappearance of the intrahepatic bile ducts and histologic changes in the liver in primary biliary cirrhosis.
    Nakanuma Y; Miyamura H; Ohta G; Kobayashi K; Kato Y; Hattori N
    Am J Gastroenterol; 1981 Dec; 76(6):506-10. PubMed ID: 7331981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When is liver biopsy needed in the diagnosis of primary biliary cirrhosis?
    Zein CO; Angulo P; Lindor KD
    Clin Gastroenterol Hepatol; 2003 Mar; 1(2):89-95. PubMed ID: 15017500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
    Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
    Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bile duct diseases and the liver. Epidemiology, pathogenesis, clinical aspects and prognosis of secondary cholangiogenic liver damage].
    Poegel K; Riedel H
    Z Arztl Fortbild (Jena); 1987; 81(14):705-8. PubMed ID: 3500551
    [No Abstract]   [Full Text] [Related]  

  • 10. Ultrastructural aspects of primary biliary cirrhosis and other types of cholestatic liver disease.
    Chedid A; Spellberg MA; DeBeer RA
    Gastroenterology; 1974 Nov; 67(5):858-69. PubMed ID: 4426490
    [No Abstract]   [Full Text] [Related]  

  • 11. The pathology of primary biliary cirrhosis and autoimmune cholangitis.
    Ludwig J
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):601-13. PubMed ID: 10976017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of primary biliary cirrhosis.
    Nishio A; Keeffe EB; Ishibashi H; Gershwin EM
    Med Sci Monit; 2000; 6(1):181-93. PubMed ID: 11208308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary biliary cirrhosis].
    Andree H
    Z Arztl Fortbild (Jena); 1988; 82(6):255-63. PubMed ID: 3043928
    [No Abstract]   [Full Text] [Related]  

  • 14. Laparoscopic findings of the liver in the diagnosis of primary biliary cirrhosis: "reddish patch", a laparoscopic feature in the asymptomatic stage.
    Minami Y; Seki K; Nishikawa M; Kawata S; Miyoshi S; Imai Y; Tarui S; Kakiuchi Y; Shinji Y; Kiyonaga G
    Endoscopy; 1982 Nov; 14(6):203-8. PubMed ID: 6216098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoteichoic acid may affect the pathogenesis of bile duct damage in primary biliary cirrhosis.
    Haruta I; Hashimoto E; Kato Y; Kikuchi K; Kato H; Yagi J; Uchiyama T; Kobayash M; Shiratori K
    Autoimmunity; 2006 Mar; 39(2):129-35. PubMed ID: 16698669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portal tract eosinophils and hepatocyte cytokeratin 7 immunoreactivity helps distinguish early-stage, mildly active primary biliary cirrhosis and autoimmune hepatitis.
    Goldstein NS; Soman A; Gordon SC
    Am J Clin Pathol; 2001 Dec; 116(6):846-53. PubMed ID: 11764073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variant forms of cholestatic diseases involving small bile ducts in adults.
    Kim WR; Ludwig J; Lindor KD
    Am J Gastroenterol; 2000 May; 95(5):1130-8. PubMed ID: 10811317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cholestatic liver diseases: diagnosis and therapy of primary biliary cirrhosis].
    Thimme R; Opitz OG; Kreisel W
    Dtsch Med Wochenschr; 2002 Sep; 127(36):1823-6. PubMed ID: 12215926
    [No Abstract]   [Full Text] [Related]  

  • 19. Possible role of endogenous retinoid (Vitamin A) toxicity in the pathophysiology of primary biliary cirrhosis.
    Erickson JM; Mawson AR
    J Theor Biol; 2000 Sep; 206(1):47-54. PubMed ID: 10968936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.
    Silveira MG; Lindor KD
    Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.